Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-02

Clinical Trial Update: Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of oral trehalose in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trehalose (trehalose)

Snippet

Sponsor: Neuromed IRCCS | Conditions: Parkinson Disease | Phase 4 | Status: UNKNOWN